Skip to main content
Premium Trial:

Request an Annual Quote

Top 10 Articles on GenomeWeb in 2017: Supreme Court Ruling; FDA Guidelines for Precision Med; More

NEW YORK (GenomeWeb) – What were the articles that gained the most interest from GenomeWeb readers this past year? The list is a cross-section of our coverage including a US Supreme Court decision, FDA guidelines, coverage of the JP Morgan Healthcare Conference, a notable acquisition, and a study of circulating tumor DNA for detecting early cancers, among others.

 Here are the top 10:

1)    Supreme Court Rules in Favor of Life Technologies in DNA Kit Component Case

2)    JPM Healthcare Day Two: 10x Genomics, Foundation Med, Quidel, Hologic, LabCorp, Nanostring, Bio-Rad

3)    FDA Releases Draft Guidelines to Clarify Regulatory Framework Supporting Precision Medicine

4)    Thermo Fisher Next-Gen Sequencing Panel Wins FDA Approval as Companion Test

5)    Illumina Launches NextSeq 550Dx, Expands Use of MiSeqDx

6)    Bio-Rad to Acquire RainDance Technologies

7)    Illumina Unveils New High-Throughput Sequencing Instrument at JP Morgan

8)    Counsyl Lays Off Oncology Sales Team

9)    FDA's Personalized Medicine Leader Leaving for Liquid Biopsy Startup Grail

10)  Sequencing of Circulating Tumor DNA Detects Early Cancers

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.